Register Today for ARM's 5th Annual Dinner and Legislative Fly-In! Celebrate the past year's accomplishments in our sector and join fellow ARM members to advocate for legislation that will lead to live-saving technologies.

The GTS held its organizational meeting to discuss the unique issues specific to gene therapy and gene-modified cell therapies on January 28, 2014.  The technology sections within ARM were established to ensure that the three major technology constituencies within ARM, are identified and recognized as primary voices within the organization.

Missed last week's Regen Med Investor Day in New York? Watch the full webcast of the program including 30 of the presenting companies, the three program panels and the event's kick-off fireside chat. 

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine.
Learn more

Our Members

140+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research, and other organizations supporting regenerative medicine.
Learn more